Neyns, B., Schwarze, J. K., Awada, G., Salama, L. B., Cremer, J. D., Fischbuch, L., . . . Duerinck, J. Axitinib plus avelumab in the treatment of recurrent glioblastoma: A stratified, open-label, single-center phase 2 clinical trial (GliAvAx). BMJ Publishing Group.
Chicago Style (17th ed.) CitationNeyns, Bart, et al. Axitinib Plus Avelumab in the Treatment of Recurrent Glioblastoma: A Stratified, Open-label, Single-center Phase 2 Clinical Trial (GliAvAx). BMJ Publishing Group.
MLA (9th ed.) CitationNeyns, Bart, et al. Axitinib Plus Avelumab in the Treatment of Recurrent Glioblastoma: A Stratified, Open-label, Single-center Phase 2 Clinical Trial (GliAvAx). BMJ Publishing Group.
Warning: These citations may not always be 100% accurate.